 Proactive Investors USA & Canada |
Transition reaches licensing deal with Eli Lilly
Reuters Lilly retains this option until the end of Phase II, and that if Lilly exercises these rights, Transition will receive milestone payments of about $250 … Transition Therapeutics acquires rights to diabetes compounds from Eli LillyProactive Investors USA & Canada Transition Therapeutics Announces Licensing and Collaboration Agreement With LillyCNNMoney.com (press release) all 53 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.